Association of Insulin Resistance, β-Cell Function Impairment and Calcium, Magnesium, and Fetuin-A Concentrations in Women with Type 2 Diabetes Mellitus
SummaryInsulin resistance and β-cell function impairment play a role in the pathogenesis of type 2 diabetes (T2DM). Insulin signaling is inhibited by fetuin-A, an abundant plasma protein. Fetuin-A is also a candidate marker of the T2DM risk. This case-control study aimed to determine whether fetuin-A serum level is related to insulin resistance, β-cell function impairment, and total and ionized Ca and Mg serum levels in Erbil patients with T2DM.A total of 60 patients with T2DM were recruited, and 30 healthy persons were included in the control group. Fetuin-A and insulin concentrations were measured through ELISA. Other biochemical parameters were determined spectrophotometrically. Insulin resistance (HOMA2IR), insulin sensitivity (HOMA2%S), and β-cell function were examined by using a homeostatic model assessment 2 (HOMA2).Fasting serum insulin, fetuin-A serum levels, and HOMA2IR were significantly increased. HOMA2%S of the patients with diabetes was significantly lower than that of the control group. The total serum and ionized Ca and Mg contents and the Ca/Mg ratio were reduced in the patients.Therefore, fetuin-A is related to T2DM pathogenesis and is strongly associated with insulin resistance and glycemic control in T2DM patients. Future large-scale studies are necessary to validate fetuin-A as an indicator of IR in T2DM patients.
References
1.
Dasgupta S, Bhattacharya S, Biswas A, Majumdar SS, Mukhopadhyay S, Ray S, et al. NF-κB mediates lipid-induced fetuin-A expression in hepatocytes that impairs adipocyte function effecting insulin resistance. Biochemical Journal. 2010;429(3):451–62.
2.
Kareem I, Jaweed SA, Bardapurkar JS, Patil VP. Study of magnesium, glycosylated hemoglobin and lipid profile in diabetic retinopathy. Indian Journal of Clinical Biochemistry. 2004;19(2):124–7.
3.
Wang H, E. Sama A. Anti-Inflammatory Role of Fetuin-A in Injury and Infection. Current Molecular Medicine. 2012;12(5):625–33.
4.
Ix JH. Fetuin-A and Incident Diabetes Mellitus in Older Persons. JAMA. 2008;300(2):182.
5.
Pham PCT, Pham PMT, Pham SV, Miller JM, Pham PTT. Hypomagnesemia in Patients with Type 2 Diabetes. Clinical Journal of the American Society of Nephrology. 2007;2(2):366–73.
6.
Milner RDG, Hales CN. The role of calcium and magnesium in insulin secretion from rabbit pancreas studied in vitro. Diabetologia. 1967;3(1):47–9.
7.
Paolisso G, Sgambato S, Pizza G, Passariello N, Varricchio M, D’Onofrio F. Improved Insulin Response and Action by Chronic Magnesium Administration in Aged NIDDM Subjects. Diabetes Care. 1989;12(4):265–9.
8.
Lorenzo C, Wagenknecht LE, D’Agostino RB, Rewers MJ, Karter AJ, Haffner SM. Insulin Resistance, β-Cell Dysfunction, and Conversion to Type 2 Diabetes in a Multiethnic Population. Diabetes Care. 2010;33(1):67–72.
9.
Guerrero-Romero F, Tamez-Perez H, González-González G, Salinas-Martínez A, Montes-Villarreal J, Treviño-Ortiz J, et al. Oral Magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial. Diabetes & Metabolism. 2004;30(3):253–8.
10.
Hu FB, Meigs JB, Li TY, Rifai N, Manson JE. Inflammatory Markers and Risk of Developing Type 2 Diabetes in Women. Diabetes. 2004;53(3):693–700.
11.
Jassem WE, Farahan AR. The Effect of Age and Gender on Fetuin-A and Some Biochemical parameters in Blood Sera of Iraqi patients with T2DM: A comparative study. Baghdad Science Journal. 12(1):197–203.
12.
Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. The Lancet. 2005;365(9467):1333–46.
13.
Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000;23(1):57–63.
14.
Schulze MB, Schulz M, Heidemann C, Schienkiewitz A, Hoffmann K, Boeing H. Carbohydrate intake and incidence of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. British Journal of Nutrition. 2008;99(5):1107–16.
15.
Stefan N, Fritsche A, Weikert C, Boeing H, Joost HG, Häring HU, et al. Plasma Fetuin-A Levels and the Risk of Type 2 Diabetes. Diabetes. 2008;57(10):2762–7.
16.
Siddiq A, Lepretre F, Hercberg S, Froguel P, Gibson F. A Synonymous Coding Polymorphism in the α2-Heremans-Schmid Glycoprotein Gene Is Associated With Type 2 Diabetes in French Caucasians. Diabetes. 2005;54(8):2477–81.
17.
Laughlin GA, Barrett-Connor E, Cummins KM, Daniels LB, Wassel CL, Ix JH. Sex-Specific Association of Fetuin-A With Type 2 Diabetes in Older Community-Dwelling Adults. Diabetes Care. 2013;36(7):1994–2000.
18.
Mori K, Emoto M, Yokoyama H, Araki T, Teramura M, Koyama H, et al. Association of Serum Fetuin-A With Insulin Resistance in Type 2 Diabetic and Nondiabetic Subjects. Diabetes Care. 2006;29(2):468–468.
19.
van Dam RM, Hu FB, Rosenberg L, Krishnan S, Palmer JR. Dietary Calcium and Magnesium, Major Food Sources, and Risk of Type 2 Diabetes in U.S. Black Women. Diabetes Care. 2006;29(10):2238–43.
20.
Ahmed LI, Mousa SG, Mohamed NAEG, Yousry ZA, Khalaa MRAE. Fetuin-A and type II diabetes mellitus. The Egyptian Journal of Internal Medicine. 2014;26(4):157–61.
21.
Koch SM, Warters RD, Mehlhorn U. The simultaneous measurement of ionized and total calcium and ionized and total magnesium in intensive care unit patients. Journal of Critical Care. 2002;17(3):203–5.
22.
Dickerson R, Alexander K, Minard G, Croce M, Brown R. Accuracy of methods to estimate ionized and “corrected” serum calcium concentrations in critically ill multiple trauma patients receiving specialized nutrition support. Journal of Parenteral and Enteral Nutrition. 2004;28(3):133–41.
23.
Zeitz U, Weber K, Soegiarto DW, Wolf E, Balling R, Erben RG. Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. The FASEB Journal. 2003;17(3):1–14.
24.
Ketteler M, Bongartz P, Westenfeld R, Wildberger JE, Mahnken AH, Böhm R, et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. The Lancet. 2003;361(9360):827–33.
25.
Pittas AG, Harris SS, Stark PC, Dawson-Hughes B. The Effects of Calcium and Vitamin D Supplementation on Blood Glucose and Markers of Inflammation in Nondiabetic Adults. Diabetes Care. 2007;30(4):980–6.
26.
Dabrowska AM, Tarach JS, Wojtysiak-Duma B, Duma D. Fetuin-A (AHSG) and its usefulness in clinical practice. Review of the literature. Biomedical Papers. 2015;159(3):352–9.
27.
Nadler JL, Buchanan T, Natarajan R, Antonipillai I, Bergman R, Rude R. Magnesium deficiency produces insulin resistance and increased thromboxane synthesis. Hypertension. 1993;21(6_pt_2):1024–9.
28.
Wild S, Roglic G, Green A, Sicree R, King H. Global Prevalence of Diabetes. Diabetes Care. 2004;27(5):1047–53.
29.
Cintrón VJ, Ko MSH, Chi KD, Gross JP, Srinivas PR, Goustin AS, et al. Genetic Mapping and Functional Studies of a Natural Inhibitor of the Insulin Receptor Tyrosine Kinase: The Mouse Ortholog of Human α2‐HS Glycoprotein. Journal of Diabetes Research. 2000;1(4):249–63.
30.
Vionnet N, Hani EH, Dupont S, Gallina S, Francke S, Dotte S, et al. Genomewide Search for Type 2 Diabetes–Susceptibility Genes in French Whites: Evidence for a Novel Susceptibility Locus for Early-Onset Diabetes on Chromosome 3q27-qter and Independent Replication of a Type 2–Diabetes Locus on Chromosome 1q21–q24. The American Journal of Human Genetics. 2000;67(6):1470–80.
31.
Ishibashi A, Ikeda Y, Ohguro T, Kumon Y, Yamanaka S, Takata H, et al. Serum Fetuin-A is an Independent Marker of Insulin Resistance in Japanese Men. Journal of Atherosclerosis and Thrombosis. 2010;17(9):925–33.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
